In pharmacology, not every new drug is a breakthrough. Me-too drugs are medications that are structurally similar to an already approved drug and act through the same mechanism of action, with only minor chemical modifications.
These drugs usually enter the market after a first-in-class (pioneer) drug and offer comparable efficacy. The differences often lie in pharmacokinetics, dosing schedule, tolerability, or cost, rather than in therapeutic innovation.
Great explanation! It’s helpful to know that ‘me-too’ drugs may be similar to existing ones but aren’t exactly the same, they can offer alternatives in dosing, tolerability, or cost, even if they aren’t major breakthroughs.